Lytic therapy in vitreous haemorrhage.
D010450:Endopeptidases / Q000627:therapeutic use*; D005128:Eye Diseases / Q000188:drug therapy; D005342:Fibrinolysis; D006470:Hemorrhage / Q000188:drug therapy*; D006801:Humans; D013997:Time Factors; D014568:Urokinase-Type Plasminogen Activator / Q000008:administration & dosage / Q000627:therapeutic use*; D014792:Visual Acuity; D014822:Vitreous Body
D010450:Endopeptidases; D014568:Urokinase-Type Plasminogen Activator